Fig. 4From: An individualized immune prognostic signature in lung adenocarcinomaIRS and ICS measured by time-dependent ROC curves at 5 years in the training dataset (a), validation dataset-1 (b), and validation dataset-2 (c). AUC area under the curve, IRS immune risk score, ICS immune clinical score, ROC receiver operator characteristicBack to article page